Showing 6,581 - 6,600 results of 31,876 for search '(( 10 ((nm decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.04s Refine Results
  1. 6581
  2. 6582
  3. 6583
  4. 6584

    Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx by Naama Lax (20998004)

    Published 2025
    “…We evaluated its efficacy and safety in pediatric patients with TMA sub-types: atypical HUS (aHUS), Shiga toxin-producing Escherichia coli (STEC)-HUS, and transplant-associated TMA (TA-TMA).…”
  5. 6585

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  6. 6586

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”
  7. 6587

    AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature by Melissa Davis (3522224)

    Published 2018
    “…AR-negative patients have a (66.60; 95% CI, 32–146) odds ratio of being basal-like compared to other PAM50 subtypes, and this is associated with an increased time to progression and decreased overall survival. …”
  8. 6588

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  9. 6589

    Reversible Triplet Excitation Transfer in a Trimethylene-Linked Thioxanthone and Benzothiophene-2-Carboxanilide that Photochemically Expels Leaving Group Anions by Gilbert N. Ndzeidze (5533625)

    Published 2018
    “…The triplet excited state of thioxanthone produced by photolysis undergoes reversible triplet energy transfer with a trimethylene-linked benzothiophene-2-carboxanilide ring system. …”
  10. 6590

    Reversible Triplet Excitation Transfer in a Trimethylene-Linked Thioxanthone and Benzothiophene-2-Carboxanilide that Photochemically Expels Leaving Group Anions by Gilbert N. Ndzeidze (5533625)

    Published 2018
    “…The triplet excited state of thioxanthone produced by photolysis undergoes reversible triplet energy transfer with a trimethylene-linked benzothiophene-2-carboxanilide ring system. …”
  11. 6591

    Reversible Triplet Excitation Transfer in a Trimethylene-Linked Thioxanthone and Benzothiophene-2-Carboxanilide that Photochemically Expels Leaving Group Anions by Gilbert N. Ndzeidze (5533625)

    Published 2018
    “…The triplet excited state of thioxanthone produced by photolysis undergoes reversible triplet energy transfer with a trimethylene-linked benzothiophene-2-carboxanilide ring system. …”
  12. 6592

    Reversible Triplet Excitation Transfer in a Trimethylene-Linked Thioxanthone and Benzothiophene-2-Carboxanilide that Photochemically Expels Leaving Group Anions by Gilbert N. Ndzeidze (5533625)

    Published 2018
    “…The triplet excited state of thioxanthone produced by photolysis undergoes reversible triplet energy transfer with a trimethylene-linked benzothiophene-2-carboxanilide ring system. …”
  13. 6593
  14. 6594

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  15. 6595

    Robustness tests. by Vivek Astvansh (14310090)

    Published 2024
    “…In a local regression discontinuity (RD) analysis, firms that narrowly pass the 50% threshold show a significant decrease in REM, relative to their peers that narrowly fail. …”
  16. 6596
  17. 6597
  18. 6598
  19. 6599

    Supplementary Material for: Topo-Proteomic in situ Analysis of Psoriatic Plaque under Efalizumab Treatment by Bonnekoh B. (4106116)

    Published 2007
    “…At the ‘EfaBS-centered, double colocation level’ a corresponding decrease was observed for CD2, CD3, CD4, CD8, CD11a, CD13, CD26, CD44, CD45, CD45R0, CD54, CD62L, HLA-DR, and TIA-1. …”
  20. 6600